Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-10-19
1994-06-07
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514454, 549407, 549340, 549387, A61K 31335, C07D31920
Patent
active
053189884
ABSTRACT:
Aminomethyl-chromans are obtained by alkylation of correspondingly substituted amines or by reductive amination of correspondingly substituted aldehydes. The aminomethyl-chromans can be used as active compounds in medicaments, in particular for the treatment of diseases of the central nervous system.
REFERENCES:
patent: 4321270 (1982-03-01), Sundeen
patent: 5126367 (1992-06-01), Stack et al.
patent: 5137901 (1992-08-01), Junge et al.
Ram Pratap, Indiana Journal of Chemistry, 11 May 1981, pub. Dec. 1981, pp. 1063-1067.
W. U. Dompert, Naunyn-Schmiedeberg's Arch Pharmacol, 1985, pp. 467-470.
Eckard Weber, Proc. Natl. Acad. Sci. USA, vol. 83, Nov. 1986, pp. 8784-8788.
Michael P. Kavanaugh, Proc. Natl. Acad. Sci., Apr. 1988, pp. 2844-2848.
W. Clark Still, J. Org. Chem., 1978, pp. 2923-2927.
Dompert Wolfgang
Glaser Thomas
Heine Hans-Georg
Junge Bodo
Schohe-Loop Rudolf
Bayer Aktiengesellschaft
Cintins Marianne M.
Peabody John
LandOfFree
2-aminomethyl-chromans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-aminomethyl-chromans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminomethyl-chromans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-792924